Advancing CAR T-Cell Therapies with Clinical Trial Customization, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how to successfully set up and manage highly customized CAR T-cell therapy clinical trials. Attendees will learn about flow cytometry's crucial role in monitoring CAR T cells in clinical trials. The featured speakers will discuss the importance of genomics to ensure patient safety. The speakers will also delve into the critical role of cytokines as biomarkers to characterize disease progression and therapy response.

TORONTO, March 25, 2024 /PRNewswire-PRWeb/ -- Bringing together best practices in genomics, flow cytometry, biomarkers and clinical trial operations.

In the ever-evolving landscape of healthcare, cell and gene therapy (CGT) stands at the forefront of groundbreaking advancements. With the power to precisely manipulate cells and genes for therapeutic purposes, it offers immense promise in treating diseases at their root. A significant breakthrough in CGT has been the use of chimeric antigen receptor-engineered T cells (CAR T cells) for treating cancer. The industry faces many challenges such as a changing complex regulatory environment and technology for CAR T-cell-based therapeutics. Introducing new CAR T-cell therapies to the market requires extensive strategizing and planning for clinical trials as well as post-marketing follow-up.

CAR T-cell therapies are highly personalized, and therefore clinical trials need customized testing solutions. The pharma and biotech communities preparing for clinical development and ultimately market launch need to consider this in their clinical trial strategies, including patient selection and therapy delivery. One key consideration is engaging with contract research organizations (CROs) and lab service providers at an early stage to ensure that clinical trials can be designed based on customized needs.

This webinar emphasizes the challenges encountered and the importance of customized solutions in genomics, flow cytometry, biomarkers and clinical trial operations for successful CAR T-cell therapy clinical trials. The expert speakers will showcase the criticality of early engagement through two case studies, demonstrating how it allows for the design of tailored trials. They will then share best practices for overcoming challenges related to (1) monitoring CAR T cells, (2) patient safety assurance and (3) assessment of therapy response.

Having supported more than 20 CAR T-cell therapy trials, Cerba Research offers extensive laboratory solutions. Join Cerba Research's webinar to learn more about customized solutions for successful CAR T-cell therapy clinical trials and stay tuned for subsequent webinars and podcasts on their other CGT solutions.

Register for this webinar today to learn more about customized solutions for successful CAR T-cell therapy clinical trials.

Join experts from Cerba Research, Goran Marinkovic, PhD, Immunologist; Nele Langenaken, General Manager; Dr. Nithianandan Selliah, PhD, Global Director, Flow Cytometry; and Dr. Karthikeyan Devaraju, PhD, Sr Scientist, Cell & Gene Therapy, for the live webinar on Monday, April 15, 2024, at 10am EDT (4pm CEST/EU-Central).

For more information, or to register for this event, visit Advancing CAR T-Cell Therapies with Clinical Trial Customization.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], https://www.xtalks.com 

SOURCE Xtalks